10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2016 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 4,237 | 2,385 |
| Marketable securities, current | 2,113 | 1,885 |
| Receivables | 5,543 | 4,299 |
| Inventories | 1,241 | 1,221 |
| Prepaid expenses and other | 570 | 625 |
| Total Current Assets | 13,704 | 10,415 |
| Property, plant and equipment | 4,980 | 4,412 |
| Goodwill | 6,875 | 6,881 |
| Other intangible assets | 1,385 | 1,419 |
| Deferred income taxes | 2,996 | 2,844 |
| Marketable securities, noncurrent | 2,719 | 4,660 |
| Other assets | 1,048 | 1,117 |
| Total Assets | 33,707 | 31,748 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term borrowings and current portion of long-term debt | 992 | 139 |
| Accounts payable | 1,664 | 1,565 |
| Accrued liabilities | 5,271 | 4,738 |
| Deferred income, current | 762 | 1,003 |
| Income taxes payable, current | 152 | 572 |
| Total Current Liabilities | 8,841 | 8,017 |
| Deferred income, noncurrent | 547 | 586 |
| Income taxes payable, noncurrent | 973 | 742 |
| Pension and other liabilities | 1,283 | 1,429 |
| Long-term debt | 5,716 | 6,550 |
| Total Liabilities | 17,360 | 17,324 |
| Commitments and contingencies (Note 18) | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 4,129 in 2016 and 4,161 in 2015, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2016 and 2015 | 221 | 221 |
| Capital in excess of par value of stock | 1,725 | 1,459 |
| Accumulated other comprehensive loss | (2,503) | (2,468) |
| Retained earnings | 33,513 | 31,613 |
| Less cost of treasury stock - 536 million common shares in 2016 and 539 million in 2015 | (16,779) | (16,559) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 16,177 | 14,266 |
| Noncontrolling interest | 170 | 158 |
| Total Equity | 16,347 | 14,424 |
| Total Liabilities and Equity | 33,707 | 31,748 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |